Co-administration increases relugolix exposure and risk of adverse reactions. If unavoidable, separate dosing by at least 6 hours and monitor frequently.
Source: NLP:relugolix
P-Gp Inhibitors (Oral) Interactions
1 interaction on record
1 interaction on record
Co-administration increases relugolix exposure and risk of adverse reactions. If unavoidable, separate dosing by at least 6 hours and monitor frequently.
Source: NLP:relugolix